{"database":"MetabolomicsWorkbench","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["http://www.metabolomicsworkbench.org/rest/study/study_id/ST001619/mwtab"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Metabolomics"],"technology_type":["NMR"],"disease":["Addiction"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001619"],"study_factor":["Phenotype:Non-Opium User","Phenotype:QC","Phenotype:Opium User"],"tissue":["Urine"],"submitter_affiliation":["University of North Carolina at Chapel Hill"],"sample_protocol":["NMR data."],"repository":["MetabolomicsWorkbench"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"Metabolomics Analysis: Opioid Addiction Project (Golestan Cohort Study) - NMR (part-II)","description":null,"dates":{"publication":""},"accession":"ST001619","cross_references":{"TAXONOMY":["9606"]}}